These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 29271929)
1. The Use of Tricyclo-DNA Oligomers for the Treatment of Genetic Disorders. Aupy P; Echevarría L; Relizani K; Goyenvalle A Biomedicines; 2017 Dec; 6(1):. PubMed ID: 29271929 [TBL] [Abstract][Full Text] [Related]
2. Use of Tricyclo-DNA Antisense Oligonucleotides for Exon Skipping. Relizani K; Goyenvalle A Methods Mol Biol; 2018; 1828():381-394. PubMed ID: 30171555 [TBL] [Abstract][Full Text] [Related]
3. Evaluating the Impact of Variable Phosphorothioate Content in Tricyclo-DNA Antisense Oligonucleotides in a Duchenne Muscular Dystrophy Mouse Model. Echevarría L; Aupy P; Relizani K; Bestetti T; Griffith G; Blandel F; Komisarski M; Haeberli A; Svinartchouk F; Garcia L; Goyenvalle A Nucleic Acid Ther; 2019 Jun; 29(3):148-160. PubMed ID: 31009315 [TBL] [Abstract][Full Text] [Related]
4. Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping Therapy. Aupy P; Echevarría L; Relizani K; Zarrouki F; Haeberli A; Komisarski M; Tensorer T; Jouvion G; Svinartchouk F; Garcia L; Goyenvalle A Mol Ther Nucleic Acids; 2020 Mar; 19():371-383. PubMed ID: 31881528 [TBL] [Abstract][Full Text] [Related]
6. The Use of Antisense Oligonucleotides for the Treatment of Duchenne Muscular Dystrophy. Relizani K; Goyenvalle A Methods Mol Biol; 2018; 1687():171-183. PubMed ID: 29067663 [TBL] [Abstract][Full Text] [Related]
7. Levels of Exon-Skipping Are Not Artificially Overestimated Because of the Increased Affinity of Tricyclo-DNA-Modified Antisense Oligonucleotides to the Target Doisy M; Vacca O; Saoudi A; Goyenvalle A Nucleic Acid Ther; 2024 Jul; ():. PubMed ID: 39046946 [TBL] [Abstract][Full Text] [Related]
8. Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders. Bizot F; Vulin A; Goyenvalle A Drugs; 2020 Sep; 80(14):1397-1415. PubMed ID: 32696107 [TBL] [Abstract][Full Text] [Related]